BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26025002)

  • 1. Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation.
    Benusiglio PR; Colas C; Rouleau E; Uhrhammer N; Romero P; Remenieras A; Moretta J; Wang Q; De Pauw A; Buecher B; Stoppa-Lyonnet D; Mouret-Fourme E; Noguès C; Di Maria M; Tlemsani C; Warcoin M; Grandjouan S; Malka D; Caron O; Blayau M
    J Med Genet; 2015 Aug; 52(8):563-5. PubMed ID: 26025002
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin germline mutation carriers: clinical management and genetic implications.
    Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
    Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing by cancer site: stomach.
    Chun N; Ford JM
    Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
    Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
    Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
    Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary diffuse gastric cancer - pathophysiology and clinical management.
    Pinheiro H; Oliveira C; Seruca R; Carneiro F
    Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1055-68. PubMed ID: 25439071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial gastric cancer and germline mutations of E-cadherin.
    Corso G; Marrelli D; Roviello F
    Ann Ital Chir; 2012; 83(3):177-82. PubMed ID: 22595728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial gastric cancer: diagnosis, treatment and periodic surveillance].
    Kluijt I; Sijmons RH; Hoogerbrugge N; Vasen HF; Cats A
    Ned Tijdschr Geneeskd; 2011; 155():A2731. PubMed ID: 21329544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer.
    Shah MA; Salo-Mullen E; Stadler Z; Ruggeri JM; Mirander M; Pristyazhnyuk Y; Zhang L
    Clin Genet; 2012 Sep; 82(3):283-7. PubMed ID: 21696387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
    Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
    Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic background and clinical features of hereditary diffuse gastric cancer].
    Vasas P; Bijendra P
    Orv Hetil; 2011 Jul; 152(28):1105-9. PubMed ID: 21737393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multidisciplinary approach allows identification of a new pathogenic CDH1 germline missense mutation in a hereditary diffuse gastric cancer family.
    Betés M; Alonso-Sierra M; Valentí V; Patiño A
    Dig Liver Dis; 2017 Jul; 49(7):825-826. PubMed ID: 28487081
    [No Abstract]   [Full Text] [Related]  

  • 16. Cate's Story: Hereditary Diffuse Gastric Cancer.
    Rogers M
    Clin J Oncol Nurs; 2016 Aug; 20(4):443-5. PubMed ID: 27441520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDH1 associated gastric cancer: a report of a family and review of the literature.
    Moran CJ; Joyce M; McAnena OJ
    Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary gastric cancer.
    Oliveira C; Seruca R; Carneiro F
    Best Pract Res Clin Gastroenterol; 2009; 23(2):147-57. PubMed ID: 19414142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer.
    Lajus TB; Sales RM
    Gene; 2015 Sep; 568(2):215-9. PubMed ID: 25981591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.